Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

Lucid may lower production guidance before Q2 earnings call, Cantor Fitzgerald analyst says, reiterates neutral rating with ...

Lucid stock has risen in the past month with a partnership announced with Uber. Can Lucid provide more positive highlights ...

Luxury electric vehicle (EV) maker Lucid Group ($LCID) will report its Q2 results on August 5. The penny stock is up 15% over ...

According to data from Fiscal AI, Wall Street expects Lucid to report second-quarter revenue of $287.20 million and a loss ...

In July 2025, the EV manufacturer also announced a partnership with Uber to develop a “next generation premium global robotaxi program.” As part of the deal, Uber to invest $300M in Lucid and plans to ...